Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia

Digestive Surgery

Volumn 19, Issue 5, 2002, Pages 349-353

  Velanovich, Vic ^a   Hollingsworth, John ^a   Suresh, Preethem ^a   Ben Menachem, Tamir ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Esophageal adenocarcinoma; Gastric cardia adenocarcinoma; Gastroesophageal junction cancer; Gastroesophageal reflux disease

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CARDIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COMORBIDITY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MALE; ODDS RATIO; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; UNITED STATES;

EID: 0036435714     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065835     Document Type: Article

References (21)

1. Kahrilas PJ: Gastroesophageal reflux disease. JAMA 1996;276:983-988.
2. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 1986;315:362-371.
3. Thomas RM, Sobin LA: Gastrointestinal cancer. Cancer 1995;75:154-170.
4. Chow WH, Finkle WD, McLaughlin JE, et al: The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. JAMA 1995;274: 474-477.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
6. Campos GMR, Peters JA, DeMeester TR, et al: Predictive Factors of Barrett's Esophagus: Multivariate Analysis of 502 Patients with GERD. 108th Scientific Session of the Western Surgical Association, Dana Point, Calif., November 2000.
7. Siewert JR, Stein HJ: Carcinoma of the cardia: Carcinoma of the gastroesophageal junction - Classification, pathology and extent of resection. Dis Esophagus 1996;9:173-182.
8. Ferguson MK: Neoplasms of the esophagus; in Bast RC Jr, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E (eds). Cancer Medicine, Ed 5. Hamilton, Decker 2000, pp 1340-1354.
9. Holscher AH, Bollschweiller E, Bumm R, et al: Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118:845-855.
10. Sonnenberg A, Delco F, El-Serag H: Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: A medical decision analysis. Dig Dis Sci 1998;43:1001-1008.
11. Pera M, Cameron AJ, Trastek VF, et al: Increasing volume of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513.
12. Katzka DA, Castell DD: Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89:989-991.
13. Haggit RC: Pathology of Barrett's esophagus. J Gastrointest Surg 2000;4:117-118.
14. Katz D, Rothstein R, Schmed A, et al: The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-541.
15. Sontag SJ, Schnell TG, Chejfec G, et al: Barrett's high grade dysplasia (HGD): Surveillance endoscopy (EGD) once a year (yr) is sufficient in most patients (pts). Gastroenterology 1999; 116:A304.
16. Ouatu-Lascar R, Triadafilopoulos G: Complete elimination of reflux symptoms does not guarantee normalization of intra-esophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1998;93:711-716.
17. Vaezi MR, Richter JE: Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995;117: 699-704.
18. DeMeester SR, Campos GMR, DeMeester TR, et al: The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg 1998;228:547-556.
19. Csendes A, Burdiles P, Bragetto I, et al: Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: The need for long-term subjective and objective follow-up. Ann Surg 2002;235:178-185.
20. DeMeester TR: Antireflux surgery in the management of Barrett's esophagus. J Gastrointest Surg 2000;4:124-128.
21. Spechler SJ, Lee E, Ahnen D, et al: Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial. JAMA 2001;285: 2331-2338.